世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

家庭用採血デバイス市場：血液サンプルの状態タイプ別（乾燥、液体）、サンプル採取方法別（フィンガースティック、プッシュボタン法）、デバイスの用途別（単回使用、再使用）、適用分野別（診断、研究、治療、その他）、主要地域別（北米、欧州、アジア太平洋地域、中南米、中東・北アフリカ地域）-産業動向と世界予測、2021-2035年

家庭用採血デバイス市場：血液サンプルの状態タイプ別（乾燥、液体）、サンプル採取方法別（フィンガースティック、プッシュボタン法）、デバイスの用途別（単回使用、再使用）、適用分野別（診断、研究、治療、その他）、主要地域別（北米、欧州、アジア太平洋地域、中南米、中東・北アフリカ地域）-産業動向と世界予測、2021-2035年


At Home Blood Collection Devices Market by Type of Blood Sample State (Dried and Liquid), Method of Sample Collection (Fingerstick and Push-Button Method), Device Usage (Single-use and Reusable), Area of Application (Diagnostics, Research, Therapeutics and Others), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and MENA) - Industry Trends and Global Forecasts, 2021-2035

世界の在宅採血市場は、2021年には7億4,700万米ドルに達し、2021年から2035年の予測期間中に10.7%のCAGRで成長すると予測されている。 COVID-19パンデミックの発生以来、潜在的な感染リスクに対する懸念から、... もっと見る

　

　

出版社 出版年月 電子版価格 納期 ページ数 言語
Roots Analysis
ルーツアナリシス 		2023年8月1日 US$4,799
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		通常3-4営業日。医療・医薬以外のレポートは10営業日 190 英語

　

サマリー

世界の在宅採血市場は、2021年には7億4,700万米ドルに達し、2021年から2035年の予測期間中に10.7%のCAGRで成長すると予測されている。

COVID-19パンデミックの発生以来、潜在的な感染リスクに対する懸念から、サンプル採取と検査のために検査施設を訪れる患者の減少が目立っている。この減少は相当なもので、世界の検査室では瀉血の予約が平均約40％減少したと報告されている。このような行動の変化により、革新的な機器や技術の開発への関心が高まり、個人が自宅で血液サンプルを採取して遠隔健康モニタリングを行えるようになった。
調査対象となった自己採血デバイスの80％以上が販売承認を得ており、この分野での著しい進歩を浮き彫りにしている。特に2021年には、TAP® IIとTasso-M20の両自己採血デバイスが欧州委員会からCEマークを取得した。さらにシンビオティカは最近、乾燥血液スポット検体を用いてSARS-CoV-2を検出できる家庭用COVID-19血清検査キットについて、USFDAから緊急使用認可を取得した。
家庭用採血・マイクロサンプリング装置市場は、新興企業、小規模企業、中堅企業を含む多様な状況を示している。興味深い発見は、この市場の新興企業の40％以上が2014年以降に設立されたということであり、これは最近の起業活動の急増を意味している。注目すべきは、大企業が戦略的に中小企業を買収し、自社の能力を強化したり、この専門分野に参入したりしていることだ。その結果、この傾向は、家庭用採血器具の領域におけるパートナーシップ活動の大幅な上昇につながっている。資金面では、2014年以来、公的・私的を問わず投資家が6億4,000万米ドル以上をこの市場に投入している。
自己採血やホームベースのサンプリング法への傾斜の高まりと、開発者やメーカーによる製品提供の拡大への継続的な努力とが相まって、家庭用採血およびマイクロサンプリング装置市場は、来るべき予測期間において大きな成長を目撃することが予測される。

レポート対象範囲
 一次調査の洞察をエグゼクティブサマリーにまとめ、家庭用採血およびマイクロサンプリングデバイス市場のハイレベルな概観を提供し、その短期的および長期的な進化を含む。
 家庭用採血およびマイクロサンプリングデバイスの紹介、各種アプリケーション、血液サンプリングタイプ、収集方法、使用デバイス、関連する利点を網羅。
 機器の分類、開発状況、規制当局の承認、技術、使用タイプ、サンプル仕様、関連企業などを網羅した詳細な市場展望分析。
 サプライヤーの専門知識と製品仕様に基づく、これらの装置の徹底的な競合分析。
 業界主要企業の経歴、本社、従業員、役員、製品ポートフォリオ、最近の活動、将来展望を詳述した包括的なプロフィール。
 この領域で2015年以降に出願／付与された特許の分析では、特許の種類、公開年、適用可能性、重点分野、活動中のプレーヤー、特許評価などのパラメータを調査する。
 2014年から2021年までの提携モデル、重点領域、治療領域、地域分布を調査した、業界プレーヤー間の最近の提携。
 この領域における投資の詳細な内訳。資金調達の事例、投資額、資金調達の種類、活動中のプレーヤー、投資家、地理的分布、目的、応用分野などのパラメータを分析。
 様々な関連要因に基づく、在宅採血およびマイクロサンプリングデバイスに関連する潜在的なコスト削減。
 2035年までの血液サンプルの状態、サンプル採取方法、装置用途、応用分野、地域別に市場を区分した市場予測分析。
 包括的な総括として、前章までのすべての重要な事実と図表を統合するとともに、この市場の将来を形成する進化的動向にスポットを当てています。

主要市場企業
 EUROIMMUN
 エブリウェル
 ラブコープ
 ラボノバム
 ラメディテック
 クエスト・ダイアグノスティックス
 スポットオンサイエンス
 タッソ
 Weavr Health
 ユアバイオヘルス

ページTOPに戻る


目次

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of At-Home Blood Collection and Micro Sampling Devices
3.3. Applications of Blood Sampling and Testing
3.3.1. Complete Blood Count
3.3.2. Basic Metabolic Panel
3.3.3. Lipoprotein Panel
3.4. Types of Blood Sampling
3.4.1. Dried Blood Sampling
3.4.2. Wet Blood Sampling

3.5. Benefits of At-Home Blood Collection
3.6. Methods Used for At-Home Blood Collection
3.6.1. Fingerstick Method
3.6.2. Press Button Method
3.6.3. Heel-stick Method
3.7. Types of At-Home Blood Collection and Micro Sampling Devices
3.7.1. Dried Blood Spot Collection Kits
3.7.2. Microtainer Tubes

3.8. Future Perspectives
4. MARKET OVERVIEW
4.1. Chapter Overview
4.2. At-Home Blood Collection and Micro Sampling Devices: Overall Market Landscape
4.2.1. Analysis by Device Class
4.2.2. Analysis by Current Status of Development
4.2.3. Analysis by Regulatory Approvals / Certifications Received
4.2.4. Analysis by Type of Technology
4.2.5. Analysis by Device Usage
4.2.6 Analysis by Type of Sample
4.2.7. Analysis by Blood Sample State
4.2.8. Analysis by Volume of Sample Collected
4.2.9. Analysis by Puncture Site
4.2.10. Analysis by Method of Sample Collection
4.2.11. Analysis by Storage Temperature
4.2.12. Analysis by Application Area
4.3. At-Home Blood Collection and Micro Sampling Devices: List of Developers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Geography
4.3.4. Analysis by Year of Establishment, Company Size and Location of Headquarters
4.4. Most Active Players: Analysis by Number of Products
5. PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Input Parameters
5.3. Methodology
5.3.1. Product Competitiveness Analysis: North America
5.3.2. Product Competitiveness Analysis: Europe
5.3.3. Product Competitiveness Analysis: Asia-Pacific
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. EUROIMMUN
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Everlywell
6.3.1. Company Overview
6.3.2. Product Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Labcorp
6.4.1. Company Overview
6.4.2. Product Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. Labonovum
6.5.1. Company Overview
6.5.2. Product Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. Lameditech
6.6.1. Company Overview
6.6.2. Product Portfolio
6.6.3. Recent Developments and Future Outlook
6.7. Quest Diagnostics
6.7.1. Company Overview
6.7.2. Product Portfolio
6.7.3. Recent Developments and Future Outlook
6.8. Spot On Sciences
6.8.1. Company Overview
6.8.2. Product Portfolio
6.8.3. Recent Developments and Future Outlook
6.9. Tasso
6.9.1. Company Overview
6.9.2. Product Portfolio
6.9.3. Recent Developments and Future Outlook
6.10. Weavr Health
6.10.1. Company Overview
6.10.2. Product Portfolio
6.10.3. Recent Developments and Future Outlook
6.11. YourBio Health
6.11.1. Company Overview
6.11.2. Product Portfolio
6.11.3. Recent Developments and Future Outlook
7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. At-Home Blood Collection and Micro Sampling Devices: Patent Analysis
7.2.1. Scope and Methodology
7.2.2. Analysis by Publication Year
7.2.3. Analysis by Publication Year and Type of Patent
7.2.4. Analysis by Geography
7.2.5. Analysis by CPC Symbols
7.2.6. Analysis by Emerging Focus Area
7.2.7. Most Active Players: Analysis by Number of Patents
7.2.8. Patent Benchmarking Analysis
7.2.9. Patent Valuation Analysis
7.2.10. Overall Intellectual Property Portfolio: Analysis by Type of Organization
8. PARTNERSHIPS
8.1. Chapter Overview
8.2. Partnership Models
8.3. At-Home Blood Collection and Micro Sampling Devices: List of Partnerships
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Focus Area
8.3.5. Analysis by Year of Partnership and Focus Area
8.3.6. Analysis by Type of Partnership and Focus Area
8.3.7. Analysis by Therapeutic Area
8.3.8. Analysis by Region
8.3.8.1. Continent-wise Distribution
8.3.8.2. Intercontinental and Intracontinental Distribution
8.3.8.3. Country-wise Distribution
8.3.9. Most Active Players: Analysis by Number of Partnerships
9. FUNDING AND INVESTMENT ANALYSIS
9.1. Chapter Overview
9.2. Types of Funding
9.3. At-Home Blood Collection and Micro Sampling Devices: Funding and Investment Analysis
9.3.1. Analysis of Number of Funding Instances by Year
9.3.2. Analysis by Amount Invested
9.3.3. Analysis by Type of Funding
9.3.4. Analysis by Year and Type of Funding
9.3.5. Analysis of Amount Invested by Geography
9.3.6. Most Active Players: Analysis by Number of Funding Instances and Amount Invested
9.3.7. Key Investors: Analysis by Number of Funding Instances
9.3.8. Analysis by Purpose of Investment
9.3.9. Analysis by Application Area
9.4. Concluding Remarks
10. COST SAVING ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions
10.3. Methodology
10.4. Overall Cost Saving Potential of At-Home Blood Collection and Micro Sampling Devices
10.5. Concluding Remarks
11. MARKET FORECAST
11.1. Chapter Overview
11.2. Forecast Methodology and Assumptions
11.3. Global At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035
11.3.1. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Blood Sample State
11.3.1.1. At-Home Blood Collection and Micro Sampling Devices Market for Dried Blood Samples, 2021-2035
11.3.1.2. At-Home Blood Collection and Micro Sampling Devices Market for Liquid Blood Samples, 2021-2035
11.3.2. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Method of Sample Collection
11.3.2.1. At-Home Blood Collection and Micro Sampling Devices Market for Fingerstick Method of Sample Collection, 2021-2035
11.3.2.2. At-Home Blood Collection and Micro Sampling Devices Market for Push-Button Method of Sample Collection, 2021-2035
11.3.3. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Device Usage
11.3.3.1. At-Home Blood Collection and Micro Sampling Devices Market for Single-use Devices, 2021-2035
11.3.3.2. At-Home Blood Collection and Micro Sampling Devices Market for Reusable Devices, 2021-2035
11.3.4. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Area of Application
11.3.4.1. At-Home Blood Collection and Micro Sampling Device Market for Diagnostics, 2021-2035
11.3.4.2. At-Home Blood Collection and Micro Sampling Device Market for Research, 2021-2035
11.3.4.3. At-Home Blood Collection and Micro Sampling Device Market for Therapeutics, 2021-2035
11.3.4.4. At-Home Blood Collection and Micro Sampling Device Market for Other Areas of Application, 2021-2035
11.3.5. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Region
11.3.5.1. At-Home Blood Collection and Micro Sampling Devices Market in North America, 2021-2035
11.3.5.2. At-Home Blood Collection and Micro Sampling Devices Market in Europe, 2021-2035
11.3.5.3. At-Home Blood Collection and Micro Sampling Devices Market in Asia-Pacific, 2021-2035
11.3.5.4. At-Home Blood Collection and Micro Sampling Devices Market in Latin America, 2021-2035
11.3.5.5. At-Home Blood Collection and Micro Sampling Devices Market in MENA, 2021-2035
12. CONCLUSION
13. EXECUTIVE INSIGHTS
13.1. Chapter Overview
13.2. Interview Transcript: Radhika Pawa, Business Development Manager, Lipomic Healthcare
14. APPENDIX I: TABULATED DATA
15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

　

ページTOPに戻る


　

Summary

The global at home blood collection market is expected to reach USD 747 million in 2021 anticipated to grow at a CAGR of 10.7% during the forecast period 2021-2035.

Since the onset of the COVID-19 pandemic, there has been a noticeable decline in patient visits to laboratories for sample collection and testing, largely due to concerns about potential infection risks. This decrease has been substantial, with laboratories globally reporting an average reduction of about 40% in phlebotomy appointments. This shift in behavior led to a growing interest in the development of innovative devices and technologies, enabling individuals to collect blood samples at home for remote health monitoring.
More than 80% of the self-blood collecting devices surveyed have received marketing approval, highlighting a significant progression in this area. Notably, in 2021, both the TAP® II and Tasso-M20 self-blood collecting devices obtained the CE mark from the European Commission. Additionally, Symbiotica recently obtained emergency use authorization from the USFDA for its at-home COVID-19 serology test kit, capable of detecting SARS-CoV-2 using dried blood spot samples.
The market for at-home blood collection and micro-sampling devices exhibits a diverse landscape, encompassing start-ups, small companies, and mid-sized firms. An intriguing revelation is that more than 40% of the start-ups in this market emerged since 2014, signifying a recent surge in entrepreneurial activity. Notably, larger companies are strategically acquiring smaller players to either bolster their capabilities or venture into this specialized sector. Consequently, this trend has led to a substantial rise in partnership activities within the domain of at-home blood collection devices. Financially, investors—both public and private—have injected over USD 640 million into this market since 2014.
With the increasing inclination towards self-blood collection and home-based sampling methods, combined with ongoing endeavors by developers and manufacturers to expand their product offerings, it is anticipated that the market for at-home blood collection and micro-sampling devices will witness significant growth in the forthcoming forecast period.

Report Coverage
 The primary research insights into an executive summary, offering a high-level overview of the at-home blood collection and micro sampling devices market, including its near-term and long-term evolution.
 Introduction of at-home blood collection and micro sampling devices, covering various applications, blood sampling types, collection methods, devices used, and associated benefits.
 Detailed market landscape analysis, encompassing device classifications, development statuses, regulatory approvals, technologies, usage types, sample specifics, companies involved, and more.
 A thorough competitive analysis of these devices based on supplier expertise and product specifications.
 A comprehensive profile of key industry players, detailing their backgrounds, headquarters, workforce, executives, product portfolios, recent activities, and future prospects.
 Analysis of patents filed/granted since 2015 within this domain, exploring parameters like patent types, publication years, applicability, focus areas, active players, and patent valuation.
 Recent partnerships between industry players, examining partnership models, focus areas, therapeutic domains, and regional distributions from 2014 to 2021.
 A detailed breakdown of investments in this domain, analyzing parameters such as funding instances, amounts invested, funding types, active players, investors, geographical distribution, purposes, and application areas.
 The potential cost savings associated with at-home blood collection and micro sampling devices based on various pertinent factors.
 A market forecast analysis, segmenting the market by blood sample state, sample collection method, device usage, application areas, and geographical regions until 2035.
 A comprehensive summary, consolidating all the key facts and figures from previous chapters, while also spotlighting evolutionary trends shaping the future of this market.

Key Market Companies
 EUROIMMUN
 Everlywell
 Labcorp
 Labonovum
 Lameditech
 Quest Diagnostics
 Spot On Sciences
 Tasso
 Weavr Health
 YourBio Health



ページTOPに戻る


Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of At-Home Blood Collection and Micro Sampling Devices
3.3. Applications of Blood Sampling and Testing
3.3.1. Complete Blood Count
3.3.2. Basic Metabolic Panel
3.3.3. Lipoprotein Panel
3.4. Types of Blood Sampling
3.4.1. Dried Blood Sampling
3.4.2. Wet Blood Sampling

3.5. Benefits of At-Home Blood Collection
3.6. Methods Used for At-Home Blood Collection
3.6.1. Fingerstick Method
3.6.2. Press Button Method
3.6.3. Heel-stick Method
3.7. Types of At-Home Blood Collection and Micro Sampling Devices
3.7.1. Dried Blood Spot Collection Kits
3.7.2. Microtainer Tubes

3.8. Future Perspectives
4. MARKET OVERVIEW
4.1. Chapter Overview
4.2. At-Home Blood Collection and Micro Sampling Devices: Overall Market Landscape
4.2.1. Analysis by Device Class
4.2.2. Analysis by Current Status of Development
4.2.3. Analysis by Regulatory Approvals / Certifications Received
4.2.4. Analysis by Type of Technology
4.2.5. Analysis by Device Usage
4.2.6 Analysis by Type of Sample
4.2.7. Analysis by Blood Sample State
4.2.8. Analysis by Volume of Sample Collected
4.2.9. Analysis by Puncture Site
4.2.10. Analysis by Method of Sample Collection
4.2.11. Analysis by Storage Temperature
4.2.12. Analysis by Application Area
4.3. At-Home Blood Collection and Micro Sampling Devices: List of Developers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Geography
4.3.4. Analysis by Year of Establishment, Company Size and Location of Headquarters
4.4. Most Active Players: Analysis by Number of Products
5. PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Input Parameters
5.3. Methodology
5.3.1. Product Competitiveness Analysis: North America
5.3.2. Product Competitiveness Analysis: Europe
5.3.3. Product Competitiveness Analysis: Asia-Pacific
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. EUROIMMUN
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Everlywell
6.3.1. Company Overview
6.3.2. Product Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Labcorp
6.4.1. Company Overview
6.4.2. Product Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. Labonovum
6.5.1. Company Overview
6.5.2. Product Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. Lameditech
6.6.1. Company Overview
6.6.2. Product Portfolio
6.6.3. Recent Developments and Future Outlook
6.7. Quest Diagnostics
6.7.1. Company Overview
6.7.2. Product Portfolio
6.7.3. Recent Developments and Future Outlook
6.8. Spot On Sciences
6.8.1. Company Overview
6.8.2. Product Portfolio
6.8.3. Recent Developments and Future Outlook
6.9. Tasso
6.9.1. Company Overview
6.9.2. Product Portfolio
6.9.3. Recent Developments and Future Outlook
6.10. Weavr Health
6.10.1. Company Overview
6.10.2. Product Portfolio
6.10.3. Recent Developments and Future Outlook
6.11. YourBio Health
6.11.1. Company Overview
6.11.2. Product Portfolio
6.11.3. Recent Developments and Future Outlook
7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. At-Home Blood Collection and Micro Sampling Devices: Patent Analysis
7.2.1. Scope and Methodology
7.2.2. Analysis by Publication Year
7.2.3. Analysis by Publication Year and Type of Patent
7.2.4. Analysis by Geography
7.2.5. Analysis by CPC Symbols
7.2.6. Analysis by Emerging Focus Area
7.2.7. Most Active Players: Analysis by Number of Patents
7.2.8. Patent Benchmarking Analysis
7.2.9. Patent Valuation Analysis
7.2.10. Overall Intellectual Property Portfolio: Analysis by Type of Organization
8. PARTNERSHIPS
8.1. Chapter Overview
8.2. Partnership Models
8.3. At-Home Blood Collection and Micro Sampling Devices: List of Partnerships
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Focus Area
8.3.5. Analysis by Year of Partnership and Focus Area
8.3.6. Analysis by Type of Partnership and Focus Area
8.3.7. Analysis by Therapeutic Area
8.3.8. Analysis by Region
8.3.8.1. Continent-wise Distribution
8.3.8.2. Intercontinental and Intracontinental Distribution
8.3.8.3. Country-wise Distribution
8.3.9. Most Active Players: Analysis by Number of Partnerships
9. FUNDING AND INVESTMENT ANALYSIS
9.1. Chapter Overview
9.2. Types of Funding
9.3. At-Home Blood Collection and Micro Sampling Devices: Funding and Investment Analysis
9.3.1. Analysis of Number of Funding Instances by Year
9.3.2. Analysis by Amount Invested
9.3.3. Analysis by Type of Funding
9.3.4. Analysis by Year and Type of Funding
9.3.5. Analysis of Amount Invested by Geography
9.3.6. Most Active Players: Analysis by Number of Funding Instances and Amount Invested
9.3.7. Key Investors: Analysis by Number of Funding Instances
9.3.8. Analysis by Purpose of Investment
9.3.9. Analysis by Application Area
9.4. Concluding Remarks
10. COST SAVING ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions
10.3. Methodology
10.4. Overall Cost Saving Potential of At-Home Blood Collection and Micro Sampling Devices
10.5. Concluding Remarks
11. MARKET FORECAST
11.1. Chapter Overview
11.2. Forecast Methodology and Assumptions
11.3. Global At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035
11.3.1. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Blood Sample State
11.3.1.1. At-Home Blood Collection and Micro Sampling Devices Market for Dried Blood Samples, 2021-2035
11.3.1.2. At-Home Blood Collection and Micro Sampling Devices Market for Liquid Blood Samples, 2021-2035
11.3.2. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Method of Sample Collection
11.3.2.1. At-Home Blood Collection and Micro Sampling Devices Market for Fingerstick Method of Sample Collection, 2021-2035
11.3.2.2. At-Home Blood Collection and Micro Sampling Devices Market for Push-Button Method of Sample Collection, 2021-2035
11.3.3. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Device Usage
11.3.3.1. At-Home Blood Collection and Micro Sampling Devices Market for Single-use Devices, 2021-2035
11.3.3.2. At-Home Blood Collection and Micro Sampling Devices Market for Reusable Devices, 2021-2035
11.3.4. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Area of Application
11.3.4.1. At-Home Blood Collection and Micro Sampling Device Market for Diagnostics, 2021-2035
11.3.4.2. At-Home Blood Collection and Micro Sampling Device Market for Research, 2021-2035
11.3.4.3. At-Home Blood Collection and Micro Sampling Device Market for Therapeutics, 2021-2035
11.3.4.4. At-Home Blood Collection and Micro Sampling Device Market for Other Areas of Application, 2021-2035
11.3.5. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2035: Analysis by Region
11.3.5.1. At-Home Blood Collection and Micro Sampling Devices Market in North America, 2021-2035
11.3.5.2. At-Home Blood Collection and Micro Sampling Devices Market in Europe, 2021-2035
11.3.5.3. At-Home Blood Collection and Micro Sampling Devices Market in Asia-Pacific, 2021-2035
11.3.5.4. At-Home Blood Collection and Micro Sampling Devices Market in Latin America, 2021-2035
11.3.5.5. At-Home Blood Collection and Micro Sampling Devices Market in MENA, 2021-2035
12. CONCLUSION
13. EXECUTIVE INSIGHTS
13.1. Chapter Overview
13.2. Interview Transcript: Radhika Pawa, Business Development Manager, Lipomic Healthcare
14. APPENDIX I: TABULATED DATA
15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Roots Analysis社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630